Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

NCT00654147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir & Lopinavir/ritonavir
DRUG: Raltegravir and emtricitabine/tenofovir

Sponsor

Margaret A. Fischl, M.D.